Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $350,000 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $700,000 | reported | |
| FY 2021 | 2021-12-31 | $1,418,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported |
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
Twelve months to Sep 30, 2026 · derived
Pulse Biosciences, Inc. is the 111th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
Latest filing Nov 6, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
141 managers · Quarter ended Sep 30, 2026All holders ›
44